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Background: We introduce a new catheter-based minimally invasive approach via frontal tuber for removing
hypertensive intraventricular hemorrhage(IVH), and further compare its treatment efficacy with conventional
external ventricular drainage (EVD).
Methods: This study is prospective and randomized. Sixty cases of secondary intraventricular cast hemorrhage
patients were randomly divided into two groups of 30 cases: modified ventricular puncture (MVP) group and
control group. Preoperative Glasgow coma scale (GCS) and Graeb score were compared between the two groups.
The postoperative manifestations of two groups were also analyzed and compared statistically, including
evacuation rate of intraventricular hematoma in 24 h, the time with drainage tube, rebleeding, complicated by
infection, shunt-dependent hydrocephalus and Glasgow outcome scale at 3 months.
Results: 1. There was no significant difference in preoperative GCS score and the Graeb score between two groups
(P > 0.05). 2. In the MVP group via frontal tuber approach, a substantial removal of intraventricular hematoma was
achieved in all cases. The average evacuation rate of intraventricular hematoma reached 80.10 ± 10.16 %, the
average time of catheter drainage was 3.17 ± 0.87 days, the average GOS was 3.80 ± 0.92, no intracranial infection
and secondary hemorrhage were observed following surgery in all cases, and shunt-dependent hydrocephalus
occurred in 2 cases. In the control group, the hematoma evacuation rate was an average of 21.21 ± 7.81 %, the
time of drainage was an average of 7.63 ± 2.87 days, the GOS was an average of 3.20 ± 1.12, intracranial infection
after surgery occurred in 5 cases, secondary hemorrhage was observed in 1 case, and shunt-dependent
hydrocephalus occurred in 8 cases. Between the two groups there were significantly statistical difference in the
hematoma evacuation rate, drainage duration, infection rate and GOS (all P < 0.05).
Conclusions: The new approach is safe, and can quickly remove the hematoma, and significantly shorten the time
with a pipe. It can also reduce the occurrence of infection and hydrocephalus, and improve overall outcome of
patients, but cannot reduce mortality.
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Intraventricular hemorrhage (IVH) is considered to be a
risk factor for poor prognosis and is characterized by a
relatively high mortality rate and morbidity. Clinicians
have long been aware of the occurrence of intraventricular
hemorrhage (IVH), which for centuries was considered to
be uniformly fatal [1–3]. This belief was based on results
from autopsy studies, in which patients with an apoplectic
onset of neurologic deterioration—progressing to coma,
brainstem dysfunction, and death—were found to have
blood diffusely within the ventricular system [1, 2, 4].
With the development of computed tomography (CT)
scanning, the diagnosis could be made in live patients,
and it was realized that individuals with IVH could survive
[1, 4, 5]. IVH occurs in 3 to 10 % of all intracerebral hem-
orrhages [1, 2]. IVHs can be classified as primary or sec-
ondary. Primary IVHs are confined to the ventricular
system and immediate parenchymal ependymal lining, ori-
ginating from intraventricular sources or a lesion in con-
tact with the ventricular wall [6, 7]. Secondary IVHs
originate as an extension of an intraparenchymal or sub-
arachnoid hemorrhage into the ventricular system [6].
About 30 % of IVHs are primary and 70 % are secondary
[8]. Our study adopted a modified ventricular puncture
external drainage to the treatment of severe secondary in-
traventricular cast hemorrhage. The goals of this study are
aimed to maintain EVD patency, dissolve intraventricular
blood clots, reduce ICP and mass effect on the ventricular
walls, help clear potentially deleterious blood breakdown
products, accelerate patient recovery, decrease the inci-
dence of hydrocephalus, and improve overall outcome.
Methods
Patients
From January 2011 to December 2013, 60 patients with
secondary intraventricular hemorrhage were treated in
our department. All patients were screened and the sur-
gical indication applied to those patients with IVH from
parenchymal hemorrhage that caused acute hydroceph-
alus. Patients with parenchymal hemorrhage not associ-
ated with IVH, patients with bleeding tendency, cerebral
aneurysm, head trauma, arteriovenous malformation
(AVM), vasculitis, hemorrhagic transformation of an
ischemic infarct, and tumors were excluded. This study
was prospective and randomized. The selected patients
were randomly divided into two groups: an EVD group
and a modified ventricular puncture (MVP) group. All
the patients enrolled have signed the inform consent.
Operation
In the EVD group, traditional EVDs were performed on
patients in the supine position under local anesthesia.
Patients with ventricular blood received continuous
drainage at 10 cm H2O until there was no furtherreduction in cerebrospinal fluid (CSF) blood content.
The EVD catheter was then sequentially weaned in daily
increments of 5 cm H2O and removed. Intraventricular
injection of an anticoagulant (urokinase) was given after
the procedure.
In the modified ventricular puncture (MVP) group,
the surgical procedure was performed with the patient
in the supine position. A 2-cm incision was made in the
frontal wrinkle scalp ipsilateral to IVH. A burr hole
(0.8 cm in diameter) was drilled using the navigator sys-
tem guide. A transcortical transventricular puncture was
made with a catheter along the parallel to ventricle dir-
ection. When the ventricle was reached, the stylet was
removed. Then the catheter continued to enter the
depth up to 10 cm, permitting the simultaneous removal
of intraventricular hematomas. The catheter was left in
the ventricle and urokinase was given after this proced-
ure. The dosage of urokinase is 100,000 units per day,
once a day. When all procedures were complete, an
EVD was left in the ventricle for 3 ± 2 days until there
was no further reduction in CSF blood content after
which it was removed.
Clinical evaluation
The clinical evaluation data included the Glasgow Coma
Scale (GCS), age, ICH volume, length of the EVD cath-
eter stay, severity of IVH, complicated by infection,
shunt-dependent hydrocephalus and Glasgow outcome
scale at 3 months. The volume of ICH was calculated
using the simplified equation 1/2 ABC. Severity of IVH
was graded according to the amount of blood in each
ventricle using the Graeb score [4] of 0 to 12, which is
the sum of the score in each ventricle; 4 is the maximum
in each lateral ventricle, and 2 is the maximum in the
third and fourth ventricles.
Statistical analysis
All statistical analyses were performed using the SPSS
13.0 Statistics program. A probability value of less than
0.05 was considered statistically significant. Normally dis-
tributed data are expressed as the means ± the standard
deviations and were compared using the unpaired t test.
Results
From January 2011 to December 2013, 60 patients with
parenchymal hemorrhage and IVH were enrolled and
treated in our department. All the patients had hyper-
tensive hemorrhaging. These patients were randomly
divided into an EVD group and an MVP group. The
clinical features of each group are shown in Table 1. No
significant differences in GCS assessment on admission
were found between the two groups. There were no sig-
nificant differences in ICH volume or Graeb score be-
tween the MVP group and the EVD group. Patients in
Table 1 Comparison of Clinical Data for the two groups(n = 30,x ± s)
Number GCS Evacuation rate % Time of drainage GOS Infection Hydrocephalus Death
MVP 30 9.50 ± 3.57 80.10 ± 10.16 3.17 ± 0.87 3.8 ± 0.92 0/30 2/30 0/30
EVD 30 9.93 ± 3.40 21.21 ± 7.81 7.63 ± 2.87 3.2 ± 1.12 5/30/2015 8/30/2015 2/30
P value P > 0.05 P < 0.01 P < 0.05 P < 0.05 P < 0.05 P < 0.05 P > 0.05
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(P < 0.05) compared with EVD group (Table 1).
In the MVP group via frontal tuber approach, a sub-
stantial removal of intraventricular hematoma was
achieved in all cases, the average evacuation rate of
intraventricular hematoma reached 80.10 ± 10.16 %, the
average time of catheter drainage was 3.17 ± 0.87 days,
the average GOS was 3.80 ± 0.92, and no intracranial
infection and secondary hemorrhage were observed
following surgery in all cases. Shunt-dependent hydro-
cephalus occurred in 2 cases. In the control group, the
hematoma evacuation rate was an average of 21.21 ±
7.81 %, the time of drainage was an average of 7.63 ±
2.87 days, and the GOS was an average of 3.20 ± 1.12,
intracranial infection after surgery occurred in 5 cases,
secondary hemorrhage was observed in 1 case, and
shunt-dependent hydrocephalus occurred in 8 cases. Be-
tween two groups there were significantly statistical dif-
ference in the hematoma evacuation rate, drainage
duration, infection rate and GOS (all P < 0.05).
Comparisons of preoperative and postoperative CT
scan are shown in the following three Figs. 1, 2 and 3.
Discussion
Most patients with IVH continue to fare very poorly. It
was once believed that the poor prognosis was because
of elevated intracranial pressure because of impaired
CSF circulation-i.e., the occurrence of obstructive hydro-
cephalus. In addition to this mechanism, it is now
known that the blood clot itself exerts a mass effect on
the ventricular walls, and may also cause damage by
means of an inflammatory reaction. CT scans may giveFig. 1 Preoperative CT scan showed the hemorrhage prior to treatment inthe false impression that intraventricular blood has re-
solved, when in actuality it has only become isodense to
the CSF normally contained within the ventricles.
Traditionally, treatment of IVH has entailed the place-
ment of one or more external ventricular drains (EVDs)
for drainage of blood and CSF from the ventricular sys-
tem and normalization of intracranial pressure. However,
this approach alone is often not sufficiently effective in
improving the poor prognosis for severe IVH [9, 10].
Patency of the EVD may be difficult to maintain. In an
effort to keep the EVD open, and to expedite the reso-
lution of the ventricular blood, clinicians have adminis-
tered fibrinolytic agents directly into the ventricular
system. Removal and/or dissolution of the intraventricu-
lar hematoma would be expected to decrease intracra-
nial pressure, increase cerebral perfusion, and minimize
the chance of IVH-induced hydrocephalus. In selected
cases, surgical evacuation of intraparenchymal and intra-
ventricular hematoma has been employed, either through
craniotomy or an endoscopic approach.
While the prognosis for IVH is not as dismal as once
believed, most patients continue to fare poorly, and im-
proved treatments need to be developed. The morbidity
and mortality of patients with IVH depend on: 1) the
underlying pathology, 2) the location of the intracranial
hematoma (in secondary IVH), and 3) the extent of the
intraventricular bleeding [3, 6, 7]. Survival of primary
IVH is common, but accompanied by considerable mor-
bidity. Patients with secondary IVH fare more poorly
than those with primary IVH [2, 7]. When an intracere-
bral hematoma extends into a portion of the ventricular
system, the mortality has been reported to be 32 tovolved the left thalamus and ruptured into the ipsilateral ventricle
Fig. 2 Repeat CT scan obtained in 24 h following surgery demonstrated the intraventricular hematoma was almost completely removed with
only a small residual clot in posterior horn; The postoperative CT scan depicted the location of the drainage catheter in 24 h after surgery
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the mortality has been 60 to 91 % [4, 7, 11, 12]. With
respect to the location of the hematoma causing the
IVH, patients with hematomas located in the thalamus
fare the worst [2].
Among the prognostic factors associated with nega-
tive outcome in patients with IVH, the volume of in-
traventricular blood is certainly one of the most
relevant [13]. Therefore, efficient and rapid removal
of intraventricular blood is the primary goal in the
management of IVH, because it will reduce ventricu-
lar dilation and a allow re-equilibration of the CSF
circulation. IVH severity influences the occurrence of
acute hydrocephalus and the initial level of conscious-
ness, which is significantly associated with prognosis.
Priority treatment of IVH should be given to those
ICH patients with IVH with Graeb score of 6 or
more [13]. Animal studies have demonstrated IVH
causes inflammatory response in epidermal and sub-
epidermal tissue layers, as well as inflammation andFig. 3 Follow-up CT scan displayed intraventricular hematoma disappearedfibrosis of the arachnoidal villi surface [14]. Therefore,
fast removal of ventricular and subarachnoid blood
may prevent prolonged irritation of the Pacchioni
granulations and ongoing inflammatory response
caused by the blood and its breakdown products. This
may result in faster recovery of the granulation and
avoid persistent hydrocephalus. In our series, the
modified ventricular puncture (MVP) group had
higher Graeb scores, but the VP shunt rate is lower
than in the EVD group. This may have occurred be-
cause our procedure can remove the intraventricular
blood faster, reduce ventricular dilatation, and reequi-
librate the CSF circulation, resulting in the avoidance
of persistent hydrocephalus. The main differences be-
tween MVP and control method are the puncture
point and puncture direction. The MVP’s puncture poin-
t:eyebrow up 2.5 cm, midline next to 1.5 cm. Puncture
direction:parallel to the baseline direction. This point lies
between anterial frontal venous and middle frontal ven-
ous. This is just the lack of blood vessels. So it is safe.completely in 7 day after surgery
Xu et al. Chinese Neurosurgical Journal  (2015) 1:12 Page 5 of 5Through this direction, the drainage tube can enter the
hematoma along the long axis of the lateral ventricle, and
we can suck out the maximum hematoma.
Compared with the traditional EVD, there are many
advantages of MVP method. Such as, it’s simple and easy
to operate, and is conducive to the popularization. It can
be carried out in the setting of small local hospitals. It
can quickly clear the hematoma and significantly shorten
the time with a pipe through MVP method. This would
also help reduce the incidence of complications.
Conclusions
The new approach of modified ventricular puncture
external drainage combined with urokinase to the treat-
ment of severe secondary intraventricular cast hemorrhage
is safe, quickly removes the hematoma, and significantly
shortens the time with a pipe, reduces the occurrence of
infection and hydrocephalus, improves overall outcome of
patients. Although it cannot reduce mortality, it is war-
ranted for promoting.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JX, XL and ZW carried out the clinical studies, participated in the design of
the study and drafted the manuscript. PL, XC and YZ participated in the
design of the study and performed the statistical analysis. YD, PS and JX
conceived of the study. BC and CD participated in its design and
coordination and helped to draft the manuscript. All authors read and




We acknowledge and thank Zhaojian Li who contributed towards the study
by making substantial contributions to conception and design, but who
does not meet the criteria for authorship. The sources of funding for all
authors are provided by the Qingdao University.
Received: 6 May 2015 Accepted: 17 September 2015
References
1. Caplan LR. Primary intraventricular hemorrhage. In: Case CS, Caplan LR,
editors. Intracerebral hemorrhage. London: Butterworth-Heinemann;
1994. p. 383–401.
2. Darby DG, Donnan GA, Saling MA, Walsh KW, Bladin PF. Primary
intraventricular hemorrhage: clinical and neuropsychological findings in a
prospective stroke series. Neurology. 1988;38:68–75.
3. Donauer E, Reif J, Mengedoht E–F, Faubert C. Intraventricular hemorrhage
caused by aneurysms and angiomas. Acta Neurochir (Wien). 1993;122:23–31.
4. Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB. Computed
tomographic diagnosis of intraventricular hemorrhage. Etiology and
prognosis. Radiology. 1982;143:91–6.
5. LeRoux PD, Haglund MM, Newell DW, Grady MS, Winn HR. Intraventricular
hemorrhage in blunt head trauma: an analysis of 43 cases. Neurosurgery.
1992;31:678–85.
6. Findlay JM, Wong JH. Clinical aspects of intraventricular hemorrhage. In:
Welch KMA, Caplan LR, Reis D, Siesjo¨ BJ, editors. Primer on cerebrovascular
diseases. San Diego: Academic; 1997. p. 437–46.
7. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood
is an important determinant of outcome in supratentorial intracerebral
hemorrhage. Crit Care Med. 1999;27:617–21.8. Andrews CO, Engelhard HH. Fibrinolytic therapy in intraventricular
hemorrhage: a review of the literature. Annal Pharmacother. 2001;35:1–13.
9. Shapiro SA, Campbell RL, Scully T. Hemorrhagic dilation on the fourth
ventricle: an ominous predictor. J Neurosurg. 1994;80:805–9.
10. Slavin KV, Ausman JI, Charbel FT, Misra M, Munoz LF. Results of the
treatment of intraventricular hemorrhage with recombinant tissue
plasminogen activator in a series of 10 patients (abstract). J Neurosurg.
1998;88:194A.
11. Jichici D, Frank Jeffrey FI. Thrombolytic therapy in neurointensive care. Crit
Care Clin. 1997;13:201–27.
12. Goh KY, Poon WS. Recombinant tissue plasminogen activator for the
treatment of spontaneous adult intraventricular hemorrhage. Surg Neurol.
1998;50:526–31.
13. Nishikawa T, Ueba T, Kajiwara M, Miyamatsu N, Yamashita K. A priority
treatment of the intraventricular hemorrhage (IVH) should be performed in
the patients suffering intracerebral hemorrhage with large IVH. Clin Neurol
Neurosurg. 2009;111:450–3.
14. Mayfrank L, Kim Y, Kissler J, Delsing P, Gilsbach JM, Schroder JM, et al.
Morphological changes following experimental intraventricular hemorrhage
and intraventricular fibrinolytic treatment with recombinant tissue
plasminogen activator. Acta Neuropathol. 2000;100:561–7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
